Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the head and neck region.
Our purpose in this study was to determine whether tumor DNA content is a prognostic factor independent of other standard clinical and histologic parameters in squamous cell carcinoma (SCC) of the head and neck region. Tumor DNA content was determined in 76 patients with primary resectable SCC of the oral cavity, larynx, or pharynx who were treated from 1978 to 1984 at the City of Hope. In addition, we measured various clinical and pathologic parameters in all patients. In comparison to patients with diploid SCC, those with aneuploid SCC had significantly decreased relapse-free and overall survival rates (p less than 0.001 for both). A Cox regression analysis demonstrated that tumor DNA content was a prognostic factor independent of all clinicopathologic features examined. By regression analysis, it was the single most important prognostic factor in determining relapse and death from SCC (p less than 0.001 for both).
Kokal
W A
WA
Department of General Oncologic Surgery, City of Hope National Medical Center, Duarte, California 91010.
Gardine
R L
RL
Sheibani
K
K
Zak
I W
IW
Beatty
J D
JD
Riihimaki
D U
DU
Wagman
L D
LD
Terz
J J
JJ
D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000032:analysis* / Q000473:pathology; D004273:DNA, Neoplasm / Q000032:analysis*; D005260:Female; D005434:Flow Cytometry; D006258:Head and Neck Neoplasms / Q000032:analysis* / Q000473:pathology; D006801:Humans; D007822:Laryngeal Neoplasms / Q000032:analysis / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000032:analysis / Q000473:pathology; D009361:Neoplasm Invasiveness; D010610:Pharyngeal Neoplasms / Q000032:analysis / Q000473:pathology; D011379:Prognosis
D004273:DNA, Neoplasm